KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemed (CHE) Debt to Equity (2016 - 2023)

Historic Debt to Equity for Chemed (CHE) over the last 15 years, with Q1 2023 value amounting to $0.02.

  • Chemed's Debt to Equity fell 8658.46% to $0.02 in Q1 2023 from the same period last year, while for Mar 2023 it was $0.02, marking a year-over-year decrease of 8658.46%. This contributed to the annual value of $0.12 for FY2022, which is 5887.37% down from last year.
  • Latest data reveals that Chemed reported Debt to Equity of $0.02 as of Q1 2023, which was down 8658.46% from $0.12 recorded in Q4 2022.
  • In the past 5 years, Chemed's Debt to Equity registered a high of $0.3 during Q4 2021, and its lowest value of $0.02 during Q1 2023.
  • In the last 5 years, Chemed's Debt to Equity had a median value of $0.17 in 2019 and averaged $0.16.
  • Its Debt to Equity has fluctuated over the past 5 years, first surged by 3762.65% in 2020, then crashed by 8658.46% in 2023.
  • Quarter analysis of 5 years shows Chemed's Debt to Equity stood at $0.12 in 2019, then soared by 88.96% to $0.23 in 2020, then rose by 26.82% to $0.3 in 2021, then crashed by 58.87% to $0.12 in 2022, then crashed by 80.22% to $0.02 in 2023.
  • Its last three reported values are $0.02 in Q1 2023, $0.12 for Q4 2022, and $0.14 during Q3 2022.